Erdem Yalçınkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erdem Yalçınkaya has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Umut Sabri Kasapoğlu
Marmara Üniversitesi
8 shared publications - Sait Karakurt
Marmara Üniversitesi
7 shared publications - Huseyin Arikan
Marmara Üniversitesi
6 shared publications - Emel Eryuksel
Department of Pulmonology, Marmara University Faculty of Medicine, 34899 Istanbul, Turkey
4 shared publications - Enes Emir İlErler
Clinical Pharmacy Department, Faculty of Pharmacy, Istinye University , Istanbul
2 shared publications - Mesut Sancar
Marmara Üniversitesi
2 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (5) , 1098-1110
Viral etiology, organ support requirements, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia
Aims: Respiratory viral pneumonia is an important cause of acute respiratory failure requiring intensive care unit admission. However, the clinical course of critically ill patients may be influenced not only by viral etiology but also by acute illness severity, organ support requirements, and microbiological co-detection. This study aimed to evaluate viral etiology, organ support requirements, microbiological findings, laboratory and radiologic characteristics, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia. Methods: This single-center, record-based observational cohort study with retrospective data extraction included adult patients admitted directly from the emergency department to a tertiary-care medical ICU with acute respiratory failure, radiographic pneumonic infiltration, and PCR-confirmed respiratory viral pneumonia. Respiratory viral PCR samples were obtained during ICU admission using nasopharyngeal swabs. The primary outcome was 28-day all-cause mortality after ICU admission. Results: Seventy-nine patients were included. The median age was 72 years, and 46 patients were male. Twenty-eight-day mortality occurred in 26 patients (32.9%). Viral etiology was heterogeneous; influenza A was the most frequent pathogen, followed by rhinovirus/enterovirus and SARS-CoV-2. No statistically significant difference was observed between survivors and non-survivors according to individual viral categories; however, viral subgroup sizes were small. Non-survivors more frequently required invasive mechanical ventilation, vasopressor support, and continuous renal replacement therapy. Respiratory-source bacterial/fungal co-detection or infection was also more frequent among non-survivors. Baseline inflammatory biomarkers and parenchymal CT patterns did not differ significantly between survivors and non-survivors. Conclusion: In this small retrospective ICU cohort of patients with PCR-confirmed respiratory viral pneumonia, 28-day mortality was substantial. Non-survivors had higher rates of organ support requirements and respiratory-source bacterial/fungal co-detection or infection, while no significant mortality difference was observed across individual viral categories. These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.
- 25 October 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (5) , 1098-1110
Open AccessViral etiology, organ support requirements, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia
Aims: Respiratory viral pneumonia is an important cause of acute respiratory failure requiring intensive care unit admission. However, the clinical course of critically ill patients may be influenced not only by viral etiology but also by acute illness severity, organ support requirements, and microbiological co-detection. This study aimed to evaluate viral etiology, organ support requirements, microbiological findings, laboratory and radiologic characteristics, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia. Methods: This single-center, record-based observational cohort study with retrospective data extraction included adult patients admitted directly from the emergency department to a tertiary-care medical ICU with acute respiratory failure, radiographic pneumonic infiltration, and PCR-confirmed respiratory viral pneumonia. Respiratory viral PCR samples were obtained during ICU admission using nasopharyngeal swabs. The primary outcome was 28-day all-cause mortality after ICU admission. Results: Seventy-nine patients were included. The median age was 72 years, and 46 patients were male. Twenty-eight-day mortality occurred in 26 patients (32.9%). Viral etiology was heterogeneous; influenza A was the most frequent pathogen, followed by rhinovirus/enterovirus and SARS-CoV-2. No statistically significant difference was observed between survivors and non-survivors according to individual viral categories; however, viral subgroup sizes were small. Non-survivors more frequently required invasive mechanical ventilation, vasopressor support, and continuous renal replacement therapy. Respiratory-source bacterial/fungal co-detection or infection was also more frequent among non-survivors. Baseline inflammatory biomarkers and parenchymal CT patterns did not differ significantly between survivors and non-survivors. Conclusion: In this small retrospective ICU cohort of patients with PCR-confirmed respiratory viral pneumonia, 28-day mortality was substantial. Non-survivors had higher rates of organ support requirements and respiratory-source bacterial/fungal co-detection or infection, while no significant mortality difference was observed across individual viral categories. These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.
- Open Access
- 30 September 2026
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 64
Patient-level critical care trajectories in adults with cystic fibrosis in Türkiye: A seven-year single-center case series
- 30 September 2026
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 64
Open AccessPatient-level critical care trajectories in adults with cystic fibrosis in Türkiye: A seven-year single-center case series
- Open Access
- 4 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 29485
Knowledge gaps in pharmacokinetically guided drug dosing for sepsis among healthcare professionals in Türkiye
- 4 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 29485
Open AccessKnowledge gaps in pharmacokinetically guided drug dosing for sepsis among healthcare professionals in Türkiye
- Open Access
- 12 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3710
Clinical Characteristics, Microbiological Sources, and Outcomes of Candida-Positive ICU Cultures in Critically Ill Adults
Background: Candida isolation is common in critically ill patients, but its clinical interpretation depends strongly on microbiological source, host factors, and clinical context. Bloodstream isolation, candiduria, respiratory tract isolation, surveillance cultures, catheter-tip cultures, and wound/skin cultures have different clinical implications. We aimed to evaluate clinical characteristics, microbiological sources, species distribution, antifungal treatment patterns, and outcomes among adult ICU patients with Candida-positive ICU cultures. Methods: This single-center retrospective observational cohort study was conducted in the medical intensive care unit of Marmara University Faculty of Medicine between 1 October 2022 and 5 September 2025. Adult ICU patients with at least one Candida-positive ICU culture were included. Non-Candida fungal isolates and duplicate patient-level records were excluded. The primary outcome was all-cause 28-day mortality. ICU mortality was defined as all-cause death during ICU stay. Source-stratified analyses and expanded multivariable logistic regression models were performed to evaluate factors associated with mortality. Results: A total of 349 adult ICU patients were included. Median age was 71 years [IQR, 62–82], and 185 patients were male (53.0%). Overall, 28-day mortality was 59.0% (206/349), and ICU mortality was 65.9% (230/349). Candida colonization was identified in 247 patients (70.8%), whereas Candida infection was identified in 102 patients (29.2%). The most common species were Candida albicans (48.4%), Candida glabrata (13.8%), and Candida auris (12.9%). The most frequent microbiological sources were urine (42.4%), lower respiratory tract samples (26.4%), and blood cultures (14.9%). Blood/sterile-site isolation was associated with higher ICU mortality than non-blood/non-sterile-site isolation (79.2% vs. 63.5%, p = 0.026), whereas the difference in 28-day mortality was not statistically significant (66.0% vs. 57.8%, p = 0.260). Antifungal treatment was more frequent among patients with blood/sterile-site isolation (94.3% vs. 16.9%, p < 0.001). In the expanded 28-day mortality model, lactate, NLR, and carbapenem exposure were independently associated with mortality. In the expanded ICU mortality model, lactate and CRRT/hemodialysis were independently associated with mortality. Candida score was not independently associated with either 28-day mortality or ICU mortality after broader adjustment. Conclusions:Candida-positive ICU cultures represent a heterogeneous clinical and microbiological spectrum. Source-specific interpretation is essential, particularly when distinguishing bloodstream or sterile-site isolation from non-sterile-site colonization. Candida score may reflect a higher-risk clinical phenotype, but it should not be interpreted as a stand-alone mortality prediction tool.
- 12 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3710
Open AccessClinical Characteristics, Microbiological Sources, and Outcomes of Candida-Positive ICU Cultures in Critically Ill Adults
Background: Candida isolation is common in critically ill patients, but its clinical interpretation depends strongly on microbiological source, host factors, and clinical context. Bloodstream isolation, candiduria, respiratory tract isolation, surveillance cultures, catheter-tip cultures, and wound/skin cultures have different clinical implications. We aimed to evaluate clinical characteristics, microbiological sources, species distribution, antifungal treatment patterns, and outcomes among adult ICU patients with Candida-positive ICU cultures. Methods: This single-center retrospective observational cohort study was conducted in the medical intensive care unit of Marmara University Faculty of Medicine between 1 October 2022 and 5 September 2025. Adult ICU patients with at least one Candida-positive ICU culture were included. Non-Candida fungal isolates and duplicate patient-level records were excluded. The primary outcome was all-cause 28-day mortality. ICU mortality was defined as all-cause death during ICU stay. Source-stratified analyses and expanded multivariable logistic regression models were performed to evaluate factors associated with mortality. Results: A total of 349 adult ICU patients were included. Median age was 71 years [IQR, 62–82], and 185 patients were male (53.0%). Overall, 28-day mortality was 59.0% (206/349), and ICU mortality was 65.9% (230/349). Candida colonization was identified in 247 patients (70.8%), whereas Candida infection was identified in 102 patients (29.2%). The most common species were Candida albicans (48.4%), Candida glabrata (13.8%), and Candida auris (12.9%). The most frequent microbiological sources were urine (42.4%), lower respiratory tract samples (26.4%), and blood cultures (14.9%). Blood/sterile-site isolation was associated with higher ICU mortality than non-blood/non-sterile-site isolation (79.2% vs. 63.5%, p = 0.026), whereas the difference in 28-day mortality was not statistically significant (66.0% vs. 57.8%, p = 0.260). Antifungal treatment was more frequent among patients with blood/sterile-site isolation (94.3% vs. 16.9%, p < 0.001). In the expanded 28-day mortality model, lactate, NLR, and carbapenem exposure were independently associated with mortality. In the expanded ICU mortality model, lactate and CRRT/hemodialysis were independently associated with mortality. Candida score was not independently associated with either 28-day mortality or ICU mortality after broader adjustment. Conclusions:Candida-positive ICU cultures represent a heterogeneous clinical and microbiological spectrum. Source-specific interpretation is essential, particularly when distinguishing bloodstream or sterile-site isolation from non-sterile-site colonization. Candida score may reflect a higher-risk clinical phenotype, but it should not be interpreted as a stand-alone mortality prediction tool.
- 20 February 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (3) , e70192
Impact of Pharmacist‐Led Antimicrobial Stewardship on Antibiotic Use in Intensive Care: A Prospective Audit and Feedback Approach
Background: Antimicrobial stewardship programs (ASPs) aim to optimize antimicrobial use in intensive care units (ICUs), where high antimicrobial consumption, antimicrobial resistance, and complex pharmacokinetics complicate therapy. Methods: This prospective, observational, pre–post study was conducted in the ICU of a tertiary hospital in Türkiye over 6 months (October 2024—April 2025), comprising a 3‐month pre‐ASP observation period and a 3‐month ASP period. During the ASP period, a clinical pharmacist integrated within a interprofessional team, including infectious disease physicians, conducted prospective audit and feedback in collaboration with the ICU team. Antimicrobial appropriateness was evaluated as the primary objective, while antimicrobial consumption (days of therapy [DOT] and length of therapy [LOT]), intervention characteristics, acceptance rates, and 30‐day mortality were assessed as secondary objectives. Results: A total of 160 patients and 466 antimicrobial treatments (235 pre‐ASP; 231 post‐ASP) were evaluated. Consistent with the primary outcome, antimicrobial appropriateness improved significantly following ASP implementation, with the inappropriateness rate decreasing from 81.7% to 8.7% ( p < 0.001), corresponding to an 89.6% reduction in antimicrobial‐related problems. Regarding secondary outcomes, overall antimicrobial exposure declined, with total DOT and LOT decreasing by 8.5% and 19.5%, respectively, although median DOT and LOT per patient‐day did not differ significantly between periods. The most frequent pharmacist interventions were dose adjustment (38.3%), initial dose selection (35.2%), and infusion duration modification (15.4%), with a 98.1% acceptance rate. Thirty‐day mortality decreased from 56.0% to 38.8% (relative risk [RR] 0.699, 95% confidence interval [CI] 0.505–0.968; p = 0.027). In adjusted patient‐level analyses, pharmacist intervention was independently associated with lower mortality (adjusted odds ratio [OR] 0.331, 95% CI 0.148–0.743; p = 0.007). Conclusion: Integration of a clinical pharmacist into a interprofessional audit and feedback process significantly improved antimicrobial appropriateness and reduced antimicrobial‐related problems. An associated reduction in 30‐day mortality was observed after adjustment for illness severity; however, this finding warrants confirmation in larger prospective studies.
- 20 February 2026
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 9 (3) , e70192
Impact of Pharmacist‐Led Antimicrobial Stewardship on Antibiotic Use in Intensive Care: A Prospective Audit and Feedback Approach
Background: Antimicrobial stewardship programs (ASPs) aim to optimize antimicrobial use in intensive care units (ICUs), where high antimicrobial consumption, antimicrobial resistance, and complex pharmacokinetics complicate therapy. Methods: This prospective, observational, pre–post study was conducted in the ICU of a tertiary hospital in Türkiye over 6 months (October 2024—April 2025), comprising a 3‐month pre‐ASP observation period and a 3‐month ASP period. During the ASP period, a clinical pharmacist integrated within a interprofessional team, including infectious disease physicians, conducted prospective audit and feedback in collaboration with the ICU team. Antimicrobial appropriateness was evaluated as the primary objective, while antimicrobial consumption (days of therapy [DOT] and length of therapy [LOT]), intervention characteristics, acceptance rates, and 30‐day mortality were assessed as secondary objectives. Results: A total of 160 patients and 466 antimicrobial treatments (235 pre‐ASP; 231 post‐ASP) were evaluated. Consistent with the primary outcome, antimicrobial appropriateness improved significantly following ASP implementation, with the inappropriateness rate decreasing from 81.7% to 8.7% ( p < 0.001), corresponding to an 89.6% reduction in antimicrobial‐related problems. Regarding secondary outcomes, overall antimicrobial exposure declined, with total DOT and LOT decreasing by 8.5% and 19.5%, respectively, although median DOT and LOT per patient‐day did not differ significantly between periods. The most frequent pharmacist interventions were dose adjustment (38.3%), initial dose selection (35.2%), and infusion duration modification (15.4%), with a 98.1% acceptance rate. Thirty‐day mortality decreased from 56.0% to 38.8% (relative risk [RR] 0.699, 95% confidence interval [CI] 0.505–0.968; p = 0.027). In adjusted patient‐level analyses, pharmacist intervention was independently associated with lower mortality (adjusted odds ratio [OR] 0.331, 95% CI 0.148–0.743; p = 0.007). Conclusion: Integration of a clinical pharmacist into a interprofessional audit and feedback process significantly improved antimicrobial appropriateness and reduced antimicrobial‐related problems. An associated reduction in 30‐day mortality was observed after adjustment for illness severity; however, this finding warrants confirmation in larger prospective studies.
- Open Access
- 1 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 314
Metabolic and Muscular Determinants of Weaning Failure: The Role of BUN/Creatinine Ratio and Rectus Femoris Thickness
Background: Weaning failure remains a major challenge in intensive care practice, often reflecting the interplay between systemic catabolism and skeletal muscle wasting. The blood urea nitrogen-to-creatinine (BUN/Cr) ratio is a routinely available biochemical index influenced by renal handling, hemodynamic status, protein metabolism, and muscle mass, and has been associated with adverse outcomes in critical illness. This study aimed to evaluate the association between BUN/Cr ratio, weaning outcomes, and ultrasound-based rectus femoris thickness. Methods: This retrospective observational study included 42 mechanically ventilated adults admitted to the medical ICU of Marmara University between December 2024 and September 2025. Rectus femoris thickness was measured via bedside ultrasonography at the time of the spontaneous breathing trial (SBT). Weaning success was defined as extubation without reintubation, death, or need for NIV/HFNO due to respiratory distress within 7 days. Laboratory and clinical variables—including BUN/Cr ratio, SOFA, APACHE II, mNUTRIC, and albumin—were recorded. Multivariable logistic regression and receiver operating characteristic (ROC) analyses were performed. Results: Weaning failure occurred in 13 patients (31.0%). These patients had higher BUN/Cr ratios (58.7 [44.6–76.9] vs. 39.7 [23.8–49.2], p = 0.007) and lower rectus femoris thickness (6.2 [5.4–7.0] vs. 7.8 [6.9–8.6] mm, p = 0.021). The BUN/Cr ratio independently predicted weaning failure (OR 1.07; 95% CI 1.01–1.14; p = 0.024). ROC analysis identified a BUN/Cr cut-off of 44.6 (AUC = 0.76) for weaning failure. An exploratory composite metabolic–muscle indicator (MMI), combining BUN/Cr ratio and rectus femoris thickness, demonstrated higher discriminative performance in this cohort (AUC = 0.81). Conclusions: An elevated BUN/Cr ratio was independently associated with weaning failure and lower rectus femoris thickness in this cohort. Given the observational design and potential confounding, these findings should be interpreted as hypothesis-generating. Combined biochemical and ultrasound-based assessment highlights the potential value of integrating metabolic and morphologic information when characterizing patients at risk for weaning failure. However, whether incorporation of such markers into clinical decision-making improves weaning outcomes requires prospective validation.
- 1 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 314
Open AccessMetabolic and Muscular Determinants of Weaning Failure: The Role of BUN/Creatinine Ratio and Rectus Femoris Thickness
Background: Weaning failure remains a major challenge in intensive care practice, often reflecting the interplay between systemic catabolism and skeletal muscle wasting. The blood urea nitrogen-to-creatinine (BUN/Cr) ratio is a routinely available biochemical index influenced by renal handling, hemodynamic status, protein metabolism, and muscle mass, and has been associated with adverse outcomes in critical illness. This study aimed to evaluate the association between BUN/Cr ratio, weaning outcomes, and ultrasound-based rectus femoris thickness. Methods: This retrospective observational study included 42 mechanically ventilated adults admitted to the medical ICU of Marmara University between December 2024 and September 2025. Rectus femoris thickness was measured via bedside ultrasonography at the time of the spontaneous breathing trial (SBT). Weaning success was defined as extubation without reintubation, death, or need for NIV/HFNO due to respiratory distress within 7 days. Laboratory and clinical variables—including BUN/Cr ratio, SOFA, APACHE II, mNUTRIC, and albumin—were recorded. Multivariable logistic regression and receiver operating characteristic (ROC) analyses were performed. Results: Weaning failure occurred in 13 patients (31.0%). These patients had higher BUN/Cr ratios (58.7 [44.6–76.9] vs. 39.7 [23.8–49.2], p = 0.007) and lower rectus femoris thickness (6.2 [5.4–7.0] vs. 7.8 [6.9–8.6] mm, p = 0.021). The BUN/Cr ratio independently predicted weaning failure (OR 1.07; 95% CI 1.01–1.14; p = 0.024). ROC analysis identified a BUN/Cr cut-off of 44.6 (AUC = 0.76) for weaning failure. An exploratory composite metabolic–muscle indicator (MMI), combining BUN/Cr ratio and rectus femoris thickness, demonstrated higher discriminative performance in this cohort (AUC = 0.81). Conclusions: An elevated BUN/Cr ratio was independently associated with weaning failure and lower rectus femoris thickness in this cohort. Given the observational design and potential confounding, these findings should be interpreted as hypothesis-generating. Combined biochemical and ultrasound-based assessment highlights the potential value of integrating metabolic and morphologic information when characterizing patients at risk for weaning failure. However, whether incorporation of such markers into clinical decision-making improves weaning outcomes requires prospective validation.
- Open Access
- 10 December 2025
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 93 (6) , 613-619
Concordancia de las brechas de CO2 medidas en sangre venosa periférica y central en pacientes diagnosticados de choque séptico
Objetivo: Evaluar la diferencia venosa-arterial de CO2 (Pv-aCO2) medida en sangre venosa periférica (Pv-aCO2p) como una alternativa menos invasiva a l...
- 10 December 2025
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 93 (6) , 613-619
Open AccessConcordancia de las brechas de CO2 medidas en sangre venosa periférica y central en pacientes diagnosticados de choque séptico
Objetivo: Evaluar la diferencia venosa-arterial de CO2 (Pv-aCO2) medida en sangre venosa periférica (Pv-aCO2p) como una alternativa menos invasiva a l...
- 26 November 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 47 (1)
Challenges in Non-Invasive Ventilation: Understanding the Causes of NIV Failure and Complications
Non-invasive ventilation (NIV) has been successfully used in the treatment of acute respiratory failure. The objective of this study was to evaluate complications arising from NIV and their impact on therapy failure, with a specific focus on identifying the most common NIV-related complication leading to NIV failure. A retrospective analysis was conducted on data from 99 patients (54 males, mean age 66 +/- 8 years) who were admitted to Internal Intensive Care Unit between January 1, 2015, and December 30, 2017. These patients received NIV due to acute respiratory failure and were monitored in the intensive care unit for more than 24 hours. The patients' demographic data, causes of acute respiratory failure, and NIV-related complications were obtained from the recorded data. Complications with NIV included discomfort, which developed in 21 patients (21%); air leakage observed in 18 patients (18%), skin erosion in 16 patients (16%), irritated and dry eyes in 9 patients (9%), skin ulcer in 5 patients (5%), abdominal tension in 3 patients (3%), claustrophobia in 2 patients (2%), and hypotension in 1 patient (1%). Univariate and multivariate analyses conducted to evaluate the factors associated with NIV failure showed that discomfort with NIV was the most common factor contributing to failure (p = 0.039). Discomfort as an NIV-related complication was identified as the main factor of failure. Choosing the right equipment, providing appropriate ventilatory support, and thorough monitoring are key to minimizing complications and maximizing the effectiveness of NIV therapy.
- 26 November 2024
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 47 (1)
Challenges in Non-Invasive Ventilation: Understanding the Causes of NIV Failure and Complications
Non-invasive ventilation (NIV) has been successfully used in the treatment of acute respiratory failure. The objective of this study was to evaluate complications arising from NIV and their impact on therapy failure, with a specific focus on identifying the most common NIV-related complication leading to NIV failure. A retrospective analysis was conducted on data from 99 patients (54 males, mean age 66 +/- 8 years) who were admitted to Internal Intensive Care Unit between January 1, 2015, and December 30, 2017. These patients received NIV due to acute respiratory failure and were monitored in the intensive care unit for more than 24 hours. The patients' demographic data, causes of acute respiratory failure, and NIV-related complications were obtained from the recorded data. Complications with NIV included discomfort, which developed in 21 patients (21%); air leakage observed in 18 patients (18%), skin erosion in 16 patients (16%), irritated and dry eyes in 9 patients (9%), skin ulcer in 5 patients (5%), abdominal tension in 3 patients (3%), claustrophobia in 2 patients (2%), and hypotension in 1 patient (1%). Univariate and multivariate analyses conducted to evaluate the factors associated with NIV failure showed that discomfort with NIV was the most common factor contributing to failure (p = 0.039). Discomfort as an NIV-related complication was identified as the main factor of failure. Choosing the right equipment, providing appropriate ventilatory support, and thorough monitoring are key to minimizing complications and maximizing the effectiveness of NIV therapy.
- 26 August 2023
- Published by Springer Nature
- p. 75-80
Nasal High Flow: Rationale and Indications